Company / Revenue
Phio Pharmaceuticals Corp. Revenue History
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$21.0K
FY2020
5-year range
$15.0K / $138.0K
FY2016-FY2020
Trend
-84.8%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $15,000 to $21,000 over the past 2 years.
Based on SEC 10-K filings.
$21,000 in FY2020 with a 3-year CAGR of +3.4%.
Improved from $15,000 to $21,000 over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +3.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +3.4%, indicating consistent growth.
- In FY2020, revenue decreased 84.8% year-over-year.
- Peak revenue was recorded in FY2019.
- Lowest revenue in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $21.0K | -84.8% |
| FY2019 | $138.0K | +820.0% |
| FY2018 | $15.0K | -21.1% |
| FY2017 | $19.0K | -44.1% |
| FY2016 | $34.0K | -64.9% |
| FY2013 | $97.0K | +0.0% |
| FY2012 | $97.0K | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026